Articles
Title
Date Published
Transfusion-acquired Trypanosoma cruzi infection.
March 1, 2007
The pathogenesis of transfusion-related acute lung injury (TRALI).
March 1, 2007
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
March 1, 2007
Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy.
March 1, 2007
Hypertonic hydroxyethyl starch solution for hypovolaemia correction following heart surgery.
March 1, 2007
Transfusion requirements and outcomes in patients undergoing abdominal aortic surgery using intra-operative cell salvage.
March 1, 2007
Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial.
March 1, 2007
Decreasing the blood transfusion rate in elective hip replacement surgery using an autologous drainage system.
March 1, 2007
An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery.
March 1, 2007
Strategy of transfusion in cardiac surgery: limits of hematocrit and how much is too low?
March 1, 2007
Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery
March 1, 2007
Clinical experience with recombinant activated factor VII in a series of 45 trauma patients.
March 1, 2007
Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas.
February 28, 2007
Phase I clinical study of eltrombopag, an oral, non- peptide thrombopoietin receptor agonist.
February 27, 2007
Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome.
February 21, 2007
Impact of vCJD on blood supply.
February 20, 2007
Living related donor nephrectomy in transfusion refusing donors.
February 19, 2007
Current role of bloodless liver resection.
February 14, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
February 14, 2007
New thrombopoietic growth factors.
February 8, 2007